Generic Product News (August 2016)

Pharmacy Times, August 2016 Pain Awareness, Volume 82, Issue 8

Read about the new generic products featured in August.

Teva Pharmaceuticals

COMPARE TO: Entocort EC (AstraZeneca)

INDICATION: Teva Pharmaceuticals recently announced the approval of Budesonide Capsules, the therapeutic equivalent of AstraZeneca’s Entocort EC, in a 3-mg dosage strength. The product is indicated to treat mild to moderate Crohn’s disease. Budesonide is a glucocorticosteroid that reduces symptoms of acute Crohn’s disease flare-ups, such as abdominal pain and diarrhea, by suppressing the body’s immune response.

INDICATION: Dosage Forms: Capsules: 3 mg

FOR MORE INFORMATION: tevagenerics.com

LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, USPMARKETED BY: Amneal Pharmaceuticals

COMPARE TO: Lutera 28 (Actavis)

INDICATION: Amneal Pharmaceuticals recently announced the launch of its AB-rated generic for Lutera 28 (levonorgestrel and ethinyl estradiol tablets USP) 0.1 mg/0.02 mg, the reference listed drug for the former Alesse brand. The product is an oral contraceptive intended for use in preventing pregnancy. Amneal’s generic will be sold under Larissia for ease of reference.

DOSAGE FORM: Tablets: 0.1 mg/0.02 mg

FOR MORE INFORMATION: amneal.com

CARBAMAZEPINE EXTENDED-RELEASE TABLETS USPMARKETED BY: Taro Pharmaceuticals

COMPARE TO: Tegretol (Sandoz)

INDICATION: Taro Pharmaceuticals recently announced the launch of Carbamazepine Extended-Release Tablets USP, the generic equivalent of Sandoz’s Tegretol. The product is an anticonvulsant and a specific analgesic for trigeminal neuralgia. Additionally, carbamazepine can treat partial seizures and generalized tonic-clonic seizures.

DOSAGE FORM: Tablets: 100 mg

FOR MORE INFORMATION: taro.com

OCTREOTIDE ACETATE INJECTIONMARKETED BY: Teva Pharmaceuticals

COMPARE TO: Sandostatin Injection (Novartis)

INDICATION: Teva Pharmaceuticals recently announced the re-launch of its Octreotide Acetate Injection, the therapeutic equivalent of Novartis’ Sandostatin Injection. The product is indicated to treat acromegaly and severe diarrhea and flushing episodes associated with metastatic carcinoid tumors.

DOSAGE FORM: Dosage Form: Injection: 0.1 mg/mL, 1000 mcg/5 mL, 0.5 mg/mL, 5000 mcg/5 mL

FOR MORE INFORMATION: tevagenerics.com